Gladstone NOW: The Campaign Join Us on the Journey✕
16 - 30 of 44 Results Clear All
Gladstone researchers discover new links between lymphoma growth and leaks in the blood-brain barrier
News Release Research (Publication) Center for Neurovascular Brain Immunology Neurological Disease Akassoglou Lab
A unique combination of expertise at Gladstone Institutes and UC San Francisco will enable new therapies for Alzheimer’s disease and multiple sclerosis
Institutional News News Release Multiple Sclerosis Alzheimer’s Disease Akassoglou Lab
The philanthropic gift will support cross-disciplinary research to find novel treatments for multiple neurological diseases
Donor Stories Multiple Sclerosis Alzheimer’s Disease Akassoglou Lab
The cells constantly survey the brain to prevent spontaneous seizures, Gladstone scientists discover
News Release Research (Publication) Multiple Sclerosis Alzheimer’s Disease Neurological Disease Akassoglou Lab Palop Lab Imaging
The 2020 Berkelhammer Scholars break new ground in research on dementias, Parkinson’s disease, and neuropsychiatric disorders
Donor Stories Parkinson’s Disease Alzheimer’s Disease Dementia Neurological Disease Akassoglou Lab Kreitzer Lab Mahley Lab Mucke Lab Nakamura Lab
San Francisco Business Times—Gabaeron, founded by Gladstone President Emeritus Bob Mahley, MD, PhD, and Therini Bio (formerly Medared), founded upon work by Senior Investigator Katarina Akassoglou, PhD, are among Bay Area biotech companies focusing on neurological diseases that collectively raised more than $3 billion from venture capital firms and the public capital markets in 2020.
Gladstone Experts Parkinson’s Disease Multiple Sclerosis Alzheimer’s Disease Neurological Disease Akassoglou Lab Mahley Lab
Drug Target Review—Senior Investigator Katerina Akassoglou, PhD, explains her team’s recent discovery of the immune cells in the brain that promote neurodegeneration in diseases such as multiple sclerosis and Alzheimer’s disease.
Gladstone Experts Multiple Sclerosis Alzheimer’s Disease Neurological Disease Akassoglou Lab
ImmunoFrontiers—Senior Investigator Katerina Akassoglou, PhD, describes her lab's recent discovery of the genetic mechanisms that drive brain inflammation in neurodegenerative diseases.
Gladstone Experts Parkinson’s Disease Multiple Sclerosis Alzheimer’s Disease Neurological Disease Akassoglou Lab
Researchers who spent decades studying human immunodeficiency virus are using some of the same tools and approaches to tackle SARS-CoV-2, the virus that causes COVID-19.
Gladstone Experts COVID-19 HIV/AIDS Center for HIV Cure Research Virology Akassoglou Lab Doudna Lab Greene Lab Ott Lab
New study generates an “atlas” of toxic immune cells in the brain.
News Release Research (Publication) Assay Development and Drug Discovery Core Neurological Disease Akassoglou Lab
Jorge Palop and Katerina Akassoglou received an NIH grant to study the link between neurovascular dysfunction and cognitive decline in Alzheimer’s disease.
News Release Research (Publication) Alzheimer’s Disease Neurological Disease Akassoglou Lab Palop Lab
Senior Investigator Katerina Akassoglou has fundamentally changed the way scientists think of neurological disorders. She made the seminal discovery that blood leaks are toxic to the brain by promoting inflammation and destroying neurons. Her research led the scientific community to reassess the complex relationship between the brain, immune, and vascular systems.
Business Development Institutional News Assay Development and Drug Discovery Core Multiple Sclerosis Alzheimer’s Disease Neurological Disease Akassoglou Lab
Interested in sports rather than science as a child, classes in biochemistry and immunology changed the game for Andrew, and inspired him to become a researcher.
Profile Akassoglou Lab
Study finds blood protein destroys memory storage sites in the brain and may lead to new treatments
News Release Research (Publication) Alzheimer’s Disease Neurological Disease Akassoglou Lab Aging
Katerina Akassoglou is selected as the 2018 recipient of the Barancik Prize for Innovation in Multiple Sclerosis Research
Awards Multiple Sclerosis Neurological Disease Akassoglou Lab
